USE OF LACIDIPIN FOR TREATMENT OF PATIENTS WITH ARTERIOSCLEROSIS

摘要

FIELD: organic chemistry, medicine, pharmacotherapy. SUBSTANCE: invention proposes the use of (E)-4-[2-[3-(1,1-dimethylethoxy)-3-oxo-1-propenyl] phenyl] -1,4- -dihydro-2,6-dimethyl-3,5-pyridine dicarboxylic acid diethyl ester for prophylaxis or treatment of patients with arteriosclerosis or for treatment of patients with arteriosclerosis and the use of this substance for prophylaxis or treatment of mammals with arteriosclerosis. This substance is administrated at effective dose. Except for, licidipin can be used for treatment of human with arteriosclerosis. EFFECT: enhanced effectiveness of prophylaxis and treatment. 4 cl